Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

1.6K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between comorbidities and major adverse cardiovascular events in patients undergoing immune checkpoint blockade.

BMC cancer·2026
Same author

Decoding sex and gender effects on health: evidence from a nationwide cohort.

Biology of sex differences·2026
Same author

Left ventricular function and its longitudinal change in Swiss childhood cancer survivors - results from the CardioOnco study.

Cardio-oncology (London, England)·2026
Same author

Incidence and management of heart failure phenotypes in patients undergoing transcatheter aortic valve implantation.

European journal of heart failure·2026
Same author

AI-echocardiography: an eagle eye for the prognostic staging of ATTR cardiomyopathy.

European journal of heart failure·2026
Same author

Undetected Heart Failure in Tertiary Care/Cardiology in Switzerland.

JACC. Heart failure·2025

Related Experiment Video

Updated: May 4, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.8K

Regenerative therapy for cardiovascular disease.

Otmar Pfister1, Giacomo Della Verde2, Ronglih Liao3

  • 1Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland; Division of Cardiology, University Hospital Basel, Basel, Switzerland.

Translational Research : the Journal of Laboratory and Clinical Medicine
|January 1, 2014
PubMed
Summary
This summary is machine-generated.

Adult heart regeneration offers new therapeutic hope. While early trials with bone marrow cells showed mixed results, newer cardiac stem cell therapies show promise for cardiovascular disease repair.

More Related Videos

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.1K
Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction
07:41

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

54.6K

Related Experiment Videos

Last Updated: May 4, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.8K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.1K
Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction
07:41

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

54.6K

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Myocardial Biology

Background:

  • The adult heart possesses a previously unrecognized regenerative capacity.
  • Discovery of dividing cardiomyocytes and cardiac stem/progenitor cells fuels hope for cardiac repair.
  • Previous cell-based therapies for heart disease yielded inconsistent clinical outcomes.

Purpose of the Study:

  • To explore the potential of various cell types for cardiac regeneration.
  • To review mechanisms of action for stem cells in the myocardium.
  • To provide an overview of clinical trials for cell-based cardiovascular therapy.

Main Methods:

  • Review of recent scientific literature on myocardial regeneration.
  • Analysis of candidate cell types and their myogenic/angiogenic potential.
  • Examination of paracrine mechanisms and clinical trial data.

Main Results:

  • Initial trials using bone marrow-derived cells showed limited functional improvement.
  • Stem cells primarily act via paracrine mechanisms in the myocardium.
  • Recent trials with cardiac-committed cells and iPSC-derived cells show promising results.

Conclusions:

  • Cell-based therapy holds potential for cardiovascular medicine.
  • Cardiac-committed cells and iPSC-derived cells represent promising future approaches.
  • Understanding cell type advantages and limitations is crucial for effective cardiac repair.